Complement-Based Drug Development Summit leaderboard
  • Wednesday, August 26, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 282

Author

Pharma Journalist 9023 posts 0 comments

Ascentage Pharma Announces Preclinical Data Demonstrating Olverembatinib’s Therapeutic…

May 19, 2022
Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that a new…
Read More...

Laekna Therapeutics Raises $61 Million in Series D financing

May 19, 2022
Laekna Therapeutics, a clinical-stage global biotechnology company dedicated to developing next generation medicines to treat cancer and liver diseases, announced that it has raised $61…
Read More...

Tonix Pharmaceuticals Extends Research Collaboration with the University of Alberta to Develop…

May 18, 2022
Tonix Pharmaceuticals Holding Corp. announced it has entered into a license agreement and extended a research collaboration with the University of Alberta, a leading Canadian research…
Read More...

PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with…

May 18, 2022
PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced a multi-year collaboration with the National Institutes of Health to develop…
Read More...

SwanBio Therapeutics Announces $56 Million Series B Financing to Advance Novel Gene Therapies for…

May 18, 2022
SwanBio Therapeutics, a gene therapy company advancing adeno-associated virus (AAV)-based therapies for the treatment of devastating, inherited neurological conditions, today announced…
Read More...

AstraZeneca signs licence agreement with RQ Biotechnology for monoclonal antibodies against COVID-19

May 18, 2022
AstraZeneca has entered into a licence agreement with RQ Biotechnology Ltd (RQ Bio) for a portfolio of early-stage monoclonal antibodies (mAbs) targeted against SARS-CoV-2, the virus…
Read More...

Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19…

May 18, 2022
Pfizer Inc. and BioNTech SE announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization (EUA) to include a booster dose after completion of the primary…
Read More...

Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell…

May 18, 2022
Sernova Corp. a clinical-stage company and leader in regenerative medicine cell therapeutics, and Evotec SE a global pharmaceutical and life science company, and leading developer of…
Read More...

Event Launch – Pre Filled Syringes San Francisco Conference

May 18, 2022
SAE Media Group’s 3rd Annual Conference Pre-Filled Syringes San Francisco September 19 - 20, 2022 | San Francisco, CA, USA http://www.prefilled-sanfrancisco.com/PR1…
Read More...

Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go Insulin…

May 17, 2022
Zealand Pharma A/S a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced it has entered into an asset purchase agreement with…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • REGENXBIO Delays RGX-121 Filing After Spine MRI Findings
  • Lundbeck Wins EU Orphan Designation for Cushing’s Syndrome Drug
  • Takeda Wins Japan Approval for New Narcolepsy Type 1 Drug
  • GSK Wins Japan Approval for Hepatitis B Functional Cure
  • Gossamer Bio Secures Up to $250 Million for Seralutinib

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.